Epigenome-wide ovarian cancer analysis identifies a methylation profile differentiating clear-cell histology with epigenetic silencing of the HERG K+ channel

Human Molecular Genetics

Volumn 22, Issue 15, 2013, Pages

  Cicek, Mine S ^a   Koestler, Devin C ^b   Fridley, Brooke L ^c   Kalli, Kimberly R ^a   Armasu, Sebastian M ^a   Larson, Melissa C ^a   Wang, Chen ^a   Winham, Stacey J ^a   Vierkant, Robert A ^a   Rider, David N ^a   Block, Matthew S ^a   Klotzle, Brandy ^d   Konecny, Gottfried ^e   Winterhoff, Boris J ^a   Hamidi, Habib ^e   Shridhar, Viji ^a   Fan, Jian Bing ^d   Visscher, Daniel W ^a   Olson, Janet E ^a   Hartmann, Lynn C ^a   Bibikova, Marina ^d   Chien, Jeremy ^c   Cunningham, Julie M ^a   Goode, Ellen L ^a   more..

^a MAYO CLINIC   (United States)

^b DARTMOUTH MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

^d ILLUMINA INC   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; POTASSIUM CHANNEL HERG; ERG1 POTASSIUM CHANNEL;

ADULT; AGED; ANK1 GENE; ARTICLE; ATXN2 GENE; CANCER PROGNOSIS; CANCER SURVIVAL; CELL PROLIFERATION; CLEAR CELL CARCINOMA; CONTROLLED STUDY; CPG ISLAND; DNA METHYLATION; DNA MICROARRAY; EPIGENETICS; FEMALE; FGFRL1 GENE; FOXP1 GENE; GENE; GENE EXPRESSION; GENE LOCUS; GENE OVEREXPRESSION; GENE SILENCING; GENETIC ASSOCIATION; GENOME ANALYSIS; HISTOLOGY; HUMAN; HUMAN TISSUE; KCNH2 GENE; LINC00340 GENE; MAJOR CLINICAL STUDY; NDRG21 GENE; NUCLEOTIDE SEQUENCE; OVARY CARCINOMA; OVERALL SURVIVAL; PRIORITY JOURNAL; SLC16A11 GENE; SURVIVAL TIME; VWA1 GENE; CANCER GRADING; CANCER STAGING; CLUSTER ANALYSIS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETIC EPIGENESIS; GENETICS; METABOLISM; MIDDLE AGED; MORTALITY; OVARY TUMOR; PATHOLOGY; PROGNOSIS; SIGNAL TRANSDUCTION; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; CLUSTER ANALYSIS; CPG ISLANDS; DNA METHYLATION; EPIGENESIS, GENETIC; EPIGENOMICS; ETHER-A-GO-GO POTASSIUM CHANNELS; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE SILENCING; HUMANS; MIDDLE AGED; NEOPLASM GRADING; NEOPLASM STAGING; OVARIAN NEOPLASMS; PROGNOSIS; SIGNAL TRANSDUCTION;

EID: 84879580092     PISSN: 09646906     EISSN: 14602083     Source Type: Journal    
DOI: 10.1093/hmg/ddt160     Document Type: Article

References (46)

1. Del Carmen, M.G., Birrer, M. and Schorge, J.O. (2012) Clear cell carcinoma of the ovary: a review of the literature. Gynecol. Oncol., 126, 481-490.
2. Pearce, C.L., Templeman, C., Rossing, M.A., Lee, A., Near, A.M., Webb, P.M., Nagle, C.M., Doherty, J.A., Cushing-Haugen, K.L., Wicklund, K.G. et al. (2012) Association between endometriosis and risk of histological subtypes of ovarian cancer: a pooled analysis of case-control studies. Lancet Oncol., 13, 385-394.
3. Prat, J. (2012) Ovarian carcinomas: five distinct diseases with different origins, genetic alterations, and clinicopathological features. Virchows Arch., 460, 237-249.
4. Ozols, R.F. (2006) Systemic therapy for ovarian cancer: current status and new treatments. Semin. Oncol., 33, S3-S11.
5. Romero, I. and Bast, R.C. Jr (2012) Minireview: human ovarian cancer: biology, current management, and paths to personalizing therapy. Endocrinology, 153, 1593-1602.
6. Siegel, R., Naishadham, D. and Jemal, A. (2012) Cancer statistics, 2012. CA Cancer J. Clin., 62, 10-29.
7. Bolton, K.L., Ganda, C., Berchuck, A., Pharaoh, P.D. and Gayther, S.A. (2012) Role of common genetic variants in ovarian cancer susceptibility and outcome: progress to date from the ovarian cancer association consortium (OCAC). J. Intern. Med., 271, 366-378.
8. White, K.L., Schildkraut, J.M., Palmieri, R.T., Iversen, E.S. Jr, Berchuck, A., Vierkant, R.A., Rider, D.N., Charbonneau, B., Cicek, M.S., Sutphen, R. et al. (2012) Ovarian cancer risk associated with inherited inflammation-related variants. Cancer Res., 72, 1064-1069.
9. Skirnisdottir, I., Seidal, T., Karlsson, M.G. and Sorbe, B. (2005) Clinical and biological characteristics of clear cell carcinomas of the ovary in FIGO stages I-II. Int. J. Oncol., 26, 177-183.
10. Schwartz, D.R., Kardia, S.L., Shedden, K.A., Kuick, R., Michailidis, G., Taylor, J.M., Misek, D.E., Wu, R., Zhai, Y., Darrah, D.M. et al. (2002) Gene expression in ovarian cancer reflects both morphology and biological behavior, distinguishing clear cell from other poor-prognosis ovarian carcinomas. Cancer Res., 62, 4722-4729.
11. Miranda, T.B. and Jones, P.A. (2007) DNA methylation: the nuts and bolts of repression. J. Cell. Physiol., 213, 384-390.
12. Lande-Diner, L., Zhang, J., Ben-Porath, I., Amariglio, N., Keshet, I., Hecht, M., Azuara, V., Fisher, A.G., Rechavi, G. and Cedar, H. (2007) Role of DNA methylation in stable gene repression. J. Biol. Chem., 282, 12194-12200.
13. Jones, P.A. and Baylin, S.B. (2007) The epigenomics of cancer. Cell, 128, 683-692.
14. Barton, C.A., Hacker, N.F., Clark, S.J. and O'Brien, P.M. (2008) DNA methylation changes in ovarian cancer: implications for early diagnosis, prognosis and treatment. Gynecol. Oncol., 109, 129-139.
15. Houshdaran, S., Hawley, S., Palmer, C., Campan, M., Olsen, M.N., Ventura, A.P., Knudsen, B.S., Drescher, C.W., Urban, N.D., Brown, P.O. et al. (2010) DNA methylation profiles of ovarian epithelial carcinoma tumors and cell lines. PLoS One, 5, e9359.
16. Campan, M., Moffitt, M., Houshdaran, S., Shen, H., Widschwendter, M., Daxenbichler, G., Long, T., Marth, C., Laird-Offringa, I.A., Press, M.F. et al. (2011) Genome-scale screen for DNA methylation-based detection markers for ovarian cancer. PLoS One, 6, e28141.
17. Cancer Genome Atlas Research Network (2011) Integrated genomic analyses of ovarian carcinoma. Nature, 474, 609-615.
18. Dai, W., Teodoridis, J.M., Zeller, C., Graham, J., Hersey, J., Flanagan, J.M., Stronach, E., Millan, D.W., Siddiqui, N., Paul, J. et al. (2011) Systematic CpG islands methylation profiling of genes in the Wnt pathway in epithelial ovarian cancer identifies biomarkers of progression-free survival. Clin. Cancer Res., 17, 4052-4062.
19. Ehrich, M., Turner, J., Gibbs, P., Lipton, L., Giovanneti, M., Cantor, C. and van den Boom, D. (2008) Cytosine methylation profiling of cancer cell lines. Proc. Natl Acad. Sci. USA, 105, 4844-4849.
20. Nautiyal, S., Carlton, V.E., Lu, Y., Ireland, J.S., Flaucher, D., Moorhead, M., Gray, J.W., Spellman, P., Mindrinos, M., Berg, P. et al. (2010) High-throughput method for analyzing methylation of CpGs in targeted genomic regions. Proc. Natl Acad. Sci. USA, 107, 12587-12592.
21. Weber, M., Hellmann, I., Stadler, M.B., Ramos, L., Paabo, S., Rebhan, M. and Schubeler, D. (2007) Distribution, silencing potential and evolutionary impact of promoter DNA methylation in the human genome. Nat. Genet., 39, 457-466.
22. Baylin, S.B. and Jones, P.A. (2011) A decade of exploring the cancer epigenome - biological and translational implications. Nat. Rev. Cancer, 11, 726-734.
23. Du, X., Han, L., Guo, A.Y. and Zhao, Z. (2012) Features of methylation and gene expression in the promoter-associated CpG islands using human methylome data. Comp. Funct. Genom., 2012, 598987.
24. McCluggage, W.G. (2011) Morphological subtypes of ovarian carcinoma: a review with emphasis on new developments and pathogenesis. Pathology, 43, 420-432.
25. Wu, Q., Lothe, R.A., Ahlquist, T., Silins, I., Trope, C.G., Micci, F., Nesland, J.M., Suo, Z. and Lind, G.E. (2007) DNA methylation profiling of ovarian carcinomas and their in vitro models identifies HOXA9, HOXB5, SCGB3A1, and CRABP1 as novel targets. Mol. Cancer, 6, 45.
26. Bol, G.M., Suijkerbuijk, K.P., Bart, J., Vooijs, M., van der Wall, E. and van Diest, P.J. (2010) Methylation profiles of hereditary and sporadic ovarian cancer. Histopathology, 57, 363-370.
27. Gloss, B.S., Patterson, K.I., Barton, C.A., Gonzalez, M., Scurry, J.P., Hacker, N.F., Sutherland, R.L., O'Brien, P.M. and Clark, S.J. (2012) Integrative genome-wide expression and promoter DNA methylation profiling identifies a potential novel panel of ovarian cancer epigenetic biomarkers. Cancer Lett., 318, 76-85.
28. Yang, H.J., Liu, V.W., Wang, Y., Tsang, P.C. and Ngan, H.Y. (2006) Differential DNA methylation profiles in gynecological cancers and correlation with clinico-pathological data. BMC Cancer, 6, 212.
29. Shih, I.-M., Chen, L., Wang, C.C., Gu, J., Davidson, B., Cope, L., Kurman, R.J., Xuan, J. and Wang, T.-L. (2010) Distinct DNA methylation profiles in ovarian serous neoplasms and their implications in ovarian carcinogenesis. Am. J. Obstet. Gynecol., 203, 584.e1-584.e22.
30. Michaelson-Cohen, R., Keshet, I., Straussman, R., Hecht, M., Cedar, H. and Beller, U. (2011) Genome-wide de novo methylation in epithelial ovarian cancer. Int. J. Gynecol. Cancer, 21, 269-279.
31. Choi, J.K. (2010) Contrasting chromatin organization of CpG islands and exons in the human genome. Genome Biol., 11, R70.
32. Jehle, J., Schweizer, P.A., Katus, H.A. and Thomas, D. (2011) Novel roles for hERG K+ channels in cell proliferation and apoptosis. Cell Death Dis., 2, e193.
33. Lang, F., Foller, M., Lang, K.S., Lang, P.A., Ritter, M., Gulbins, E., Vereninov, A. and Huber, S.M. (2005) Ion channels in cell proliferation and apoptotic cell death. J. Membr. Biol., 205, 147-157.
34. Cherubini, A., Taddei, G.L., Crociani, O., Paglierani, M., Buccoliero, A.M., Fontana, L., Noci, I., Borri, P., Borrani, E., Giachi, M. et al. (2000) HERG potassium channels are more frequently expressed in human endometrial cancer as compared to non-cancerous endometrium. Br. J. Cancer, 83, 1722-1729.
35. Asher, V., Warren, A., Shaw, R., Sowter, H., Bali, A. and Khan, R. (2011) The role of Eag and HERG channels in cell proliferation and apoptotic cell death in SK-OV-3 ovarian cancer cell line. Cancer Cell Int., 11, 6.
36. Asher, V., Khan, R., Warren, A., Shaw, R., Schalkwyk, G.V., Bali, A. and Sowter, H.M. (2010) The Eag potassium channel as a new prognostic marker in ovarian cancer. Diagn. Pathol., 5, 78.
37. Bibikova, M., Barnes, B., Tsan, C., Ho, V., Klotzle, B., Le, J.M., Delano, D., Zhang, L., Schroth, G.P., Gunderson, K.L. et al. (2011) High density DNA methylation array with single CpG site resolution. Genomics, 98, 288-295.
38. Sandoval, J., Heyn, H.A., Moran, S., Serra-Musach, J., Pujana, M.A., Bibikova, M. and Esteller, M. (2011) Validation of a DNA methylation microarray for 450,000 CpG sites in the human genome. Epigenetics, 6, 692-702.
39. Chen, C., Grennan, K., Badner, J., Zhang, D., Gershon, E., Jin, L. and Liu, C. (2011) Removing batch effects in analysis of expression microarray data: an evaluation of six batch adjustment methods. PLoS One, 6, e17238.
40. Johnson, W.E., Li, C. and Rabinovic, A. (2007) Adjusting batch effects in microarray expression data using empirical Bayes methods. Biostatistics, 8, 118-127.
41. Koestler, D.C., Marsit, C.J., Christensen, B.C., Karagas, M.R., Bueno, R., Sugarbaker, D.J., Kelsey, K.T. and Houseman, E.A. (2010) Semi-supervised recursively partitioned mixture models for identifying cancer subtypes. Bioinformatics, 26, 2578-2585.
42. Kuan, P.F., Wang, S., Zhou, X. and Chu, H. (2010) A statistical framework for Illumina DNA methylation arrays. Bioinformatics, 26, 2849-2855.
43. Houseman, E.A., Christensen, B.C., Yeh, R.F., Marsit, C.J., Karagas, M.R., Wrensch, M., Nelson, H.H., Wiemels, J., Zheng, S., Wiencke, J.K. et al. (2008) Model-based clustering of DNA methylation array data: a recursive-partitioning algorithm for high-dimensional data arising as a mixture of beta distributions. BMC Bioinformatics, 9, 365.
44. Koestler, D.C., Marsit, C.J., Christensen, B.C., Accomando, W., Langevin, S.M., Houseman, E.A., Nelson, H.H., Karagas, M.R., Wiencke, J.K. and Kelsey, K.T. (2012) Peripheral blood immune cell methylation profiles are associated with nonhematopoietic cancers. Cancer Epidemiol. Biomarkers Prev., 21, 1293-1302.
45. Christensen, B.C., Smith, A.A., Zheng, S., Koestler, D.C., Houseman, E.A., Marsit, C.J., Wiemels, J.L., Nelson, H.H., Karagas, M.R., Wrensch, M.R. et al. (2011) DNA methylation, isocitrate dehydrogenase mutation, and survival in glioma. J. Natl. Cancer Inst., 103, 143-153.
46. Langevin, S.M., Koestler, D.C., Christensen, B.C., Butler, R.A., Wiencke, J.K., Nelson, H.H., Houseman, E.A., Marsit, C.J. and Kelsey, K.T. (2012) Peripheral blood DNA methylation profiles are indicative of head and neck squamous cell carcinoma: an epigenome-wide association study. Epigenetics, 7, 291-299.